ELOXX PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2025
Total Assets: $5.3M
Liabilities Breakdown FY2025
Total Liabilities: $17.2M
Asset Breakdown
Total Assets: $5.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.8M | 90.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $485.0K | 9.2% |
Liabilities Breakdown
Total Liabilities: $17.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.7M | 15.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $14.5M | 84.2% |